Development of novel therapies for CNS tumors requires reliable assessment of response and progression. This requirement has been particularly challenging in neuro-oncology for which contrast enhancement serves as an imperfect surrogate for tumor volume and is influenced by agents that affect vascul...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!